Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Chalet Hotels lists with 3.93% premium on the BSE

07-Feb2019

Chalet Hotels lists with 3.93% premium on the BSE

Chalet Hotels has debuted at Rs 291.00 on the BSE, up by 11 point or 3.93% from its issue price of Rs 280.

The scrip is currently trading at Rs 285.90, up by 5.90 points or 2.11% from its issue price. It has touched a high and low of Rs 293.50 and Rs 250.15 respectively. So far 4,36,000 shares were traded on the counter.

The offering, which was open for subscription between January 29, 2019 and January 31, 2019, was subscribed 1.02 times. The issue price was fixed at Rs 280 per share i.e. at upper end of price band of Rs 275-280 apiece.

Chalet Hotels is an owner, developer and asset manager of high-end hotels in key metro cities in India.


Related News

View all news

SpiceJet flies high on the bourses

Spicejet is currently trading at Rs. 77.25, up by 0.65 points or 0.85% from its previous closing of Rs. 76.60 on the BSE.The scrip opened at Rs. 76.90 and has touched a high and low of Rs. 78.00 and Rs.......

Linde India gains on reporting 62% rise in Q4 net profit

Linde India is currently trading at Rs. 436.00, up by 3.05 points or 0.70% from its previous closing of Rs. 432.95 on the BSE.The scrip opened at Rs. 440.00 and has touched a high and low of Rs. 443.75......

Tata Motors surges on the bourses

Tata Motors is currently trading at Rs. 165.30, up by 1.80 points or 1.10% from its previous closing of Rs. 163.50 on the BSE.The scrip opened at Rs. 165.00 and has touched a high and low of Rs. 166.50......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......